Harrow, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Harrow, Inc. (HROW) reported Cash and Cash Equivalents, Period Increase (Decrease) of $2.10 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-13.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2018-11-13
- Harrow, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was $2.15M.
- Harrow, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $1.28M.
- Harrow, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was -$1.33M.
- Harrow, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was $152.00K, a 97.66% decline year-over-year.
- Harrow, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$4.83M, a 178.37% decline from fiscal 2016.
- Harrow, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $6.17M.
- Harrow, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$5.53M.
- Harrow, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2014 was -$7.37M, a 232.91% decline from fiscal 2013.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 155 month | Cash and Cash Equivalents, Period Increase (Decrease) 158 month | Cash and Cash Equivalents, Period Increase (Decrease) 161 month | Cash and Cash Equivalents, Period Increase (Decrease) 164 month | Cash and Cash Equivalents, Period Increase (Decrease) 167 month | Cash and Cash Equivalents, Period Increase (Decrease) 170 month | Cash and Cash Equivalents, Period Increase (Decrease) 173 month | Cash and Cash Equivalents, Period Increase (Decrease) 176 month | Cash and Cash Equivalents, Period Increase (Decrease) 182 month | Cash and Cash Equivalents, Period Increase (Decrease) 185 month | Cash and Cash Equivalents, Period Increase (Decrease) 188 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | $2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $3.42M derived: sum of 2 quarters · filed 2018-11-13 | $2.10M 10-Q · filed 2018-11-13 | $2.25M derived: sum of 4 quarters · filed 2018-11-13 | |||||||||||||||
| 2018-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$49.00K 10-Q · filed 2018-08-06 | $103.00K derived: sum of 3 quarters · filed 2018-08-06 | -$195.00K derived: sum of 4 quarters · filed 2018-11-13 | |||||||||||||||
| 2018-03-31 | -$1.33M 10-Q · filed 2018-05-15 | -$1.18M derived: sum of 2 quarters · filed 2018-05-15 | -$1.47M derived: sum of 3 quarters · filed 2018-11-13 | -$4.70M derived: sum of 4 quarters · filed 2018-11-13 | |||||||||||||||
| 2017-12-31 | $152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$146.00K derived: sum of 2 quarters · filed 2018-11-13 | -$3.38M derived: sum of 3 quarters · filed 2018-11-13 | -$4.83M 10-K · filed 2018-03-08 | |||||||||||||||
| 2017-09-30 | -$298.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$3.53M derived: sum of 2 quarters · filed 2018-11-13 | -$4.99M 10-Q · filed 2018-11-13 | $1.50M derived: sum of 4 quarters · filed 2018-11-13 | |||||||||||||||
| 2017-06-30 | -$3.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$4.69M 10-Q · filed 2018-08-06 | $1.80M derived: sum of 3 quarters · filed 2018-08-06 | -$1.28M derived: sum of 4 quarters · filed 2018-08-06 | |||||||||||||||
| 2017-03-31 | -$1.46M 10-Q · filed 2018-05-15 | $5.03M derived: sum of 2 quarters · filed 2018-05-15 | $1.96M derived: sum of 3 quarters · filed 2018-05-15 | -$4.42M derived: sum of 4 quarters · filed 2018-05-15 | |||||||||||||||
| 2016-12-31 | $6.49M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $3.41M derived: sum of 2 quarters · filed 2018-03-08 | -$2.97M derived: sum of 3 quarters · filed 2018-03-08 | $6.17M 10-K · filed 2018-03-08 | |||||||||||||||
| 2016-09-30 | -$3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$9.46M derived: sum of 2 quarters · filed 2017-11-14 | -$323.00K 10-Q · filed 2017-11-14 | -$4.19M derived: sum of 4 quarters · filed 2017-11-14 | |||||||||||||||
| 2016-06-30 | -$6.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $2.76M 10-Q · filed 2017-08-10 | -$1.11M derived: sum of 3 quarters · filed 2017-08-10 | -$4.61M derived: sum of 4 quarters · filed 2017-08-10 | |||||||||||||||
| 2016-03-31 | $9.14M 10-Q · filed 2017-05-10 | $5.26M derived: sum of 2 quarters · filed 2017-05-10 | $1.77M derived: sum of 3 quarters · filed 2017-05-10 | $8.92M derived: sum of 4 quarters · filed 2017-05-10 | |||||||||||||||
| 2015-12-31 | -$3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | -$7.37M derived: sum of 2 quarters · filed 2017-03-21 | -$213.00K derived: sum of 3 quarters · filed 2017-03-21 | -$5.53M 10-K · filed 2017-03-21 | |||||||||||||||
| 2015-09-30 | -$3.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $3.66M derived: sum of 2 quarters · filed 2016-11-14 | -$1.66M 10-Q · filed 2016-11-14 | -$3.81M derived: sum of 4 quarters · filed 2016-11-14 | |||||||||||||||
| 2015-06-30 | $7.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $1.84M 10-Q · filed 2016-08-15 | -$313.00K derived: sum of 3 quarters · filed 2016-08-15 | -$2.05M derived: sum of 4 quarters · filed 2016-08-15 | |||||||||||||||
| 2015-03-31 | -$5.31M 10-Q · filed 2016-05-12 | -$7.47M derived: sum of 2 quarters · filed 2016-05-12 | -$9.20M derived: sum of 3 quarters · filed 2016-05-12 | -$11.30M derived: sum of 4 quarters · filed 2016-05-12 | |||||||||||||||
| 2014-12-31 | -$2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | -$3.89M derived: sum of 2 quarters · filed 2016-03-23 | -$5.99M derived: sum of 3 quarters · filed 2016-03-23 | -$7.37M 10-K · filed 2016-03-23 | -$7.37M 10-K · filed 2015-03-12 | ||||||||||||||
| 2014-09-30 | -$1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$3.84M derived: sum of 2 quarters · filed 2015-11-12 | -$5.21M 10-Q · filed 2015-11-12 | -$5.22M 10-Q · filed 2014-11-12 | -$6.46M derived: sum of 4 quarters · filed 2015-11-12 | ||||||||||||||
| 2014-06-30 | -$2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$3.48M 10-Q · filed 2015-08-12 | -$3.48M 10-Q · filed 2014-08-13 | -$4.73M derived: sum of 3 quarters · filed 2015-08-12 | -$5.87M derived: sum of 4 quarters · filed 2015-08-12 | ||||||||||||||
| 2014-03-31 | -$1.38M 10-Q · filed 2015-05-13 | -$1.38M 10-Q · filed 2014-05-15 | -$2.63M derived: sum of 2 quarters · filed 2015-05-13 | -$3.77M derived: sum of 3 quarters · filed 2015-05-13 | -$4.78M derived: sum of 4 quarters · filed 2015-05-13 | $14.20M 10-Q · filed 2014-05-15 | |||||||||||||
| 2013-12-31 | -$1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$2.39M derived: sum of 2 quarters · filed 2015-03-12 | -$3.40M derived: sum of 3 quarters · filed 2015-03-12 | $5.54M 10-K · filed 2015-03-12 | $15.58M 10-K · filed 2014-03-28 | ||||||||||||||
| 2013-09-30 | -$1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$2.15M derived: sum of 2 quarters · filed 2014-11-12 | $6.79M 10-Q · filed 2014-11-12 | $5.84M derived: sum of 4 quarters · filed 2014-11-12 | $16.83M 10-Q · filed 2013-11-06 | ||||||||||||||
| 2013-06-30 | -$1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $7.93M 10-Q · filed 2014-08-13 | $6.98M derived: sum of 3 quarters · filed 2014-08-13 | $10.25M derived: sum of 4 quarters · filed 2014-08-13 | $17.97M 10-Q · filed 2013-08-14 | ||||||||||||||
| 2013-03-31 | $8.94M 10-Q · filed 2014-05-15 | $7.99M derived: sum of 2 quarters · filed 2014-05-15 | $11.26M derived: sum of 3 quarters · filed 2014-05-15 | $18.83M derived: sum of 4 quarters · filed 2014-05-15 | $18.98M 10-Q · filed 2013-05-08 | ||||||||||||||
| 2012-12-31 | -$955.26K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $2.32M derived: sum of 2 quarters · filed 2014-03-28 | $9.89M derived: sum of 3 quarters · filed 2014-03-28 | $9.89M 10-K · filed 2014-03-28 | $10.04M 10-K · filed 2013-03-18 | ||||||||||||||
| 2012-09-30 | $3.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $10.84M derived: sum of 2 quarters · filed 2013-11-06 | $10.84M 10-Q · filed 2013-11-06 | $10.99M derived: sum of 4 quarters · filed 2013-11-06 | $10.99M 10-Q · filed 2012-11-14 | ||||||||||||||
| 2012-06-30 | $7.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $7.57M 10-Q · filed 2013-08-14 | $7.72M derived: sum of 3 quarters · filed 2013-08-14 | $7.71M derived: sum of 4 quarters · filed 2013-08-14 | $7.72M 10-Q · filed 2012-08-14 | ||||||||||||||
| 2012-03-31 | $551.00 10-Q · filed 2013-05-08 | $144.56K derived: sum of 2 quarters · filed 2013-05-08 | $141.16K derived: sum of 3 quarters · filed 2013-05-08 | $75.84K derived: sum of 4 quarters · filed 2013-05-08 | $146.71K 10-Q · filed 2012-05-10 | ||||||||||||||
| 2011-12-31 | $144.01K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $140.61K derived: sum of 2 quarters · filed 2013-03-18 | $75.29K derived: sum of 3 quarters · filed 2013-03-18 | -$145.30K 10-K · filed 2013-03-18 | $146.16K 10-K · filed 2012-02-23 | ||||||||||||||
| 2011-09-30 | -$3.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$68.71K derived: sum of 2 quarters · filed 2012-11-14 | -$289.31K 10-Q · filed 2012-11-14 | -$465.12K derived: sum of 4 quarters · filed 2012-11-14 | $2.15K 10-Q · filed 2012-02-23 | ||||||||||||||
| 2011-06-30 | -$65.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$285.91K 10-Q · filed 2012-08-14 | -$461.73K derived: sum of 3 quarters · filed 2012-08-14 | -$1.04M derived: sum of 4 quarters · filed 2012-08-14 | $5.55K 10-Q · filed 2012-02-23 | ||||||||||||||
| 2011-03-31 | -$220.60K 10-Q · filed 2012-05-10 | -$396.41K derived: sum of 2 quarters · filed 2012-05-10 | -$971.75K derived: sum of 3 quarters · filed 2012-05-10 | ||||||||||||||||
| 2010-12-31 | -$175.82K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | -$751.15K derived: sum of 2 quarters · filed 2012-02-23 | -$1.30M 10-K · filed 2012-02-23 | ||||||||||||||||
| 2010-09-30 | -$575.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-23 | -$1.12M 10-Q · filed 2012-02-23 | |||||||||||||||||
| 2010-06-30 | -$547.16K 10-Q · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |